Evidence map›Paper›PMID 24631742›Full record

ArticleStem cell research2014

Utilization of the AAVS1 safe harbor locus for hematopoietic specific transgene expression and gene knockdown in human ES cells.

Amita Tiyaboonchai, Helen Mac, Razveen Shamsedeen, Jason A Mills, Siddarth Kishore, Deborah L French, Paul Gadue

Open access · goldAbstract readEvaluation Study
In one paragraph

Article in Stem cell research, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Probing pluripotency gene regulatory networks with quantitative live cell imaging.Computational and structural biotechnology journal · 2020
    Review
  12. Review
  13. Article
  14. Article
  15. CRISPR/Cas9-Based Cellular Engineering for Targeted Gene Overexpression.International journal of molecular sciences · 2018
    Article
  16. Article
  17. Article
  18. Article
  19. Genome editing: a robust technology for human stem cells.Cellular and molecular life sciences : CMLS · 2017
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Amita TiyaboonchaiSchool of Arts and Sciences, University of Pennsylvania, Philadelphia, PA, USA; Center for Cellular and Molecular Therapeutics, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Helen MacCenter for Cellular and Molecular Therapeutics, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Razveen ShamsedeenCenter for Cellular and Molecular Therapeutics, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Jason A MillsCenter for Cellular and Molecular Therapeutics, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Siddarth KishoreCenter for Cellular and Molecular Therapeutics, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Deborah L FrenchCenter for Cellular and Molecular Therapeutics, The Children's Hospital of Philadelphia, Philadelphia, PA, USA; Department of Pathology and Laboratory Medicine, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Paul GadueCenter for Cellular and Molecular Therapeutics, The Children's Hospital of Philadelphia, Philadelphia, PA, USA; Department of Pathology and Laboratory Medicine, The Children's Hospital of Philadelphia, Philadelphia, PA, USA. Electronic address: gaduep@email.chop.edu.
Children's Hospital of Philadelphia · US

Funding

Safety &Efficacy of Intravas. Del. of AAV-F.IX to Skeletal MuscleP01HL064190 · NHLBI · CHILDREN'S HOSP OF PHILADELPHIA · PI ARRUDA, VALDER R. · 2000 to 2015
$27.8M
Protein CoreP01HL110860 · NHLBI · CHILDREN'S HOSP OF PHILADELPHIA · PI RAUOVA, LUBICA · 2012 to 2016
$11.4M
Embryonic Stem Cell-Derived Platelets as Cellular TherapeuticsU01HL099656 · NHLBI · CHILDREN'S HOSP OF PHILADELPHIA · PI PONCZ, MORTIMER · 2009 to 2015
$8.6M
Controlling Hematopoietic Lineage Commitment from ESC to PlateletsU01HL099993 · NHLBI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI TOROK-STORB, BEVERLY J. · 2009 to 2015
$8.3M
Research BaseP30DK090969 · NIDDK · CHILDREN'S HOSP OF PHILADELPHIA · PI CARROLL, MARTIN · 2010 to 2015
$5.7M
NHLBI NIH HHS P01 HL064190NHLBI NIH HHS P01 HL110860NHLBI NIH HHS U01 HL099656NHLBI NIH HHS U01 HL099993NIDDK NIH HHS P30 DK090969
6 · The paper itself

Abstract

Human pluripotent stem cells offer a powerful system to study human biology and disease. Here, we report a system to both express transgenes specifically in ES cell derived hematopoietic cells and knockdown gene expression stably throughout the differentiation of ES cells. We characterize a CD43 promoter construct that when inserted into the AAVS1 "safe harbor" locus utilizing a zinc finger nuclease specifically drives GFP expression in hematopoietic cells derived from a transgenic ES cell line and faithfully recapitulates endogenous CD43 expression. In addition, using the same gene targeting strategy we demonstrate that constitutive expression of short hairpin RNAs within a microRNA backbone can suppress expression of PU.1, an important regulator of myeloid cell development. We show that PU.1 knockdown cell lines display an inhibition in myeloid cell formation and skewing towards erythroid development. Overall, we have generated a powerful system to track hematopoietic development from pluripotent stem cells and study gene function through hematopoietic specific gene expression and constitutive gene knockdown.

Indexed as

Gene ExpressionEmbryonic Stem CellsGene Knockdown TechniquesGenes, ReporterGene TargetingGenetic LociGenetic VectorsGreen Fluorescent ProteinsHematopoietic Stem CellsHumansLeukosialinPluripotent Stem CellsRecombinant Fusion ProteinsRecombination, GeneticTransgenesGreen Fluorescent ProteinsLeukosialinRecombinant Fusion Proteins

Identifiers

PMID24631742
PMCPMC4048956
OpenAlexW1980424282

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.